文献
J-GLOBAL ID:201902240625825693
整理番号:19A2679898
脳に入り,細胞外α-シヌクレインを隔離し,in vivoでのα-シヌクレイン拡散を減弱させる高親和性α-シヌクレイン抗体,Medi1341の前臨床的開発【JST・京大機械翻訳】
Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo
著者 (26件):
Schofield Darren J.
(Antibody Discovery & Protein Engineering, R&D, AstraZeneca, Cambridge, UK)
,
Irving Lorraine
(Antibody Discovery & Protein Engineering, R&D, AstraZeneca, Cambridge, UK)
,
Calo Laura
(Department of Clinical Neurosciences, University of Cambridge, UK)
,
Bogstedt Anna
(Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Huddinge, Sweden)
,
Rees Gareth
(Antibody Discovery & Protein Engineering, R&D, AstraZeneca, Cambridge, UK)
,
Nuccitelli Annalisa
(Antibody Discovery & Protein Engineering, R&D, AstraZeneca, Cambridge, UK)
,
Narwal Rajesh
(Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gaithersburg, US)
,
Petrone Marcella
(Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK)
,
Roberts Jennifer
(Antibody Discovery & Protein Engineering, R&D, AstraZeneca, Cambridge, UK)
,
Brown Lee
(Antibody Discovery & Protein Engineering, R&D, AstraZeneca, Cambridge, UK)
,
Cusdin Fiona
(Antibody Discovery & Protein Engineering, R&D, AstraZeneca, Cambridge, UK)
,
Dosanjh Bhupinder
(Antibody Discovery & Protein Engineering, R&D, AstraZeneca, Cambridge, UK)
,
Lloyd Christopher
(Antibody Discovery & Protein Engineering, R&D, AstraZeneca, Cambridge, UK)
,
Dobson Claire
(Antibody Discovery & Protein Engineering, R&D, AstraZeneca, Cambridge, UK)
,
Gurrell Ian
(Neuroscience, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK)
,
Fraser Graham
(Neuroscience, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK)
,
McFarlane Mary
(Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK)
,
Rockenstein Edward
(Departments of Neurosciences and Pathology, University of California and San Diego, US)
,
Spencer Brian
(Departments of Neurosciences and Pathology, University of California and San Diego, US)
,
Masliah Eliezer
(Departments of Neurosciences and Pathology, University of California and San Diego, US)
,
Spillantini Maria Grazia
(Department of Clinical Neurosciences, University of Cambridge, UK)
,
Tan Keith
(Neuroscience, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK)
,
Billinton Andrew
(Neuroscience, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK)
,
Vaughan Tris
(Antibody Discovery & Protein Engineering, R&D, AstraZeneca, Cambridge, UK)
,
Chessell Iain
(Neuroscience, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK)
,
Perkinton Michael S.
(Neuroscience, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK)
資料名:
Neurobiology of Disease
(Neurobiology of Disease)
巻:
132
ページ:
Null
発行年:
2019年
JST資料番号:
W1774A
ISSN:
0969-9961
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)